Des chercheurs ont montré que le SARS-CoV-2 se multiplie efficacement dans les voies respiratoires, qu’il cible principalement les cellules ciliées de l’épithélium et détruit leurs cils. Cette détérioration est associée à une inhibition du mécanisme de clairance mucociliée. Ce mécanisme permet d’évacuer ...
An article published in JAMA Internal Medicine and WHO meta-analysis of 27 controlled trials confirm the promising initial results of the test-CORIMUNO TOCI-1, indicating an improved prognosis of patients with moderate to severe COVID-19 pneumonia. ...
The aim of the AP-HP - ARNCombi trial is to compare the immunological efficacy of the standard vaccine regimen with two doses of the same mRNA vaccine against Covid-19 with a regimen combining two different mRNA vaccines (one dose of Moderna vaccine ...
The teams of the cardiac and thoracic surgery departments and intensive medicine-intensive care of the Pitié-Salpêtrière hospital AP-HP, Sorbonne University and the Inserm, reported the results of the ECMO in the care of patients with extremely serious respiratory damage caused by Covid-19, ...
In a new study, researchers show that a significant proportion of patients who were hospitalized and followed up as part of French COVID continue to have symptoms three and six months after infection. ...
Loss of smell, or anosmia, is one of the earliest and most commonly reported symptoms of COVID-19. ...
Press release
14.12.2021
Press release
21.10.2021
06.12.2021
09.12.2021